Post-dural Puncture Headache: A Retrospective Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03790124 |
|
Recruitment Status :
Completed
First Posted : December 31, 2018
Last Update Posted : June 19, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Neuraxial techniques are widely used in obstetric practice to provide analgesia and anesthesia. A common complication associated with neuraxial anesthesia is post-dural puncture headache (PDPH), resulting from unintentional or unintended puncture of the dura mater during insertion of an epidural needle. Incidence of PDPH after spinal anesthesia is very low due to the widespread use of non-cutting small diameter spinal needles. Incidence of "wet tap" during epidural injection has been reported to be 1.5%, with 52-85% of these patients developing PDPH.
When an obstetric patient develops PDPH, institution of an effective treatment is necessary. Although PDPH tends to resolve spontaneously over a couple of weeks, it carries the risk of potential complications. PDPH interfere with the ability of the mother to take care of her baby, increases the risk of chronic headache and limits early ambulation, thereby increasing the risk of venous thrombosis and pulmonary embolism. As important as treating PDPH when it occurs is to prevent it when the dura is accidentally punctured during labor epidural placement. Multiple therapeutic strategies have been reported in the medical literature to prevent this outcome. Preventive measures range from conservative strategies to invasive procedures. Bedrest and hydration have been traditionally recommended to try to prevent PDPH when a wet tap occurs; however, no conclusive evidence supports their use. The use of oral and intravenous caffeine is insufficiently supported by clinical evidence. Epidural morphine and intravenous cosyntropin have been successfully used to prevent PDPH. Epidural injection of normal saline reduces the gradient for CSF leak. The use of saline has shown variable results in different studies. Although the results of some studies show insufficient evidence about its effectiveness, administration of epidural saline is a technique relatively devoid of significant adverse effects.
The institutional protocol recommends the combination of a multimodal approach to prevention of PDPH after accidental dural puncture, based on strategies reported in the medical literature. The protocol consists of the immediate administration of 60 cc of epidural normal saline, followed by two preventive measures administered after delivery. After delivery, 1 mg of intravenous cosyntropin and 3 mg of epidural morphine before catheter removal are administered. This study tests the hypothesis that the multimodal prophylactic protocol described above decreases the incidence of PDPH and the need to perform epidural blood patch, compared to other strategies or no prophylactic management.
| Condition or disease |
|---|
| Obstetric Anesthesia Problems Headache Epidural; Anesthesia, Headache |
| Study Type : | Observational |
| Actual Enrollment : | 50 participants |
| Observational Model: | Other |
| Time Perspective: | Retrospective |
| Official Title: | Effectiveness of a Multimodal Prophylactic Strategy to Treat Post-dural Puncture Headache: A Retrospective Study |
| Actual Study Start Date : | February 1, 2019 |
| Actual Primary Completion Date : | March 1, 2019 |
| Actual Study Completion Date : | March 30, 2019 |
- Number of cases with Postdural puncture headache [ Time Frame: 3 days after delivery ]Number of patients who had wet tap during epidural placement who developed postdural puncture headache
- Number of cases of epidural patch placement [ Time Frame: 3 days after delivery ]Number of patients who had wet tap during epidural placement who developed postdural puncture and required performance of epidural blood patch
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Pregnant patients who underwent labor epidural and had accidental dural puncture
Exclusion Criteria:
- History of migraines or chronic headaches
- History of neurological deficits
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03790124
| United States, Georgia | |
| Augusta University | |
| Augusta, Georgia, United States, 30912 | |
| Responsible Party: | Efrain Riveros Perez, MD, Assistant Professor. Department of Anesthesiology, Augusta University |
| ClinicalTrials.gov Identifier: | NCT03790124 |
| Other Study ID Numbers: |
1218545 |
| First Posted: | December 31, 2018 Key Record Dates |
| Last Update Posted: | June 19, 2019 |
| Last Verified: | June 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Post-Dural Puncture Headache Headache Pain Neurologic Manifestations Headache Disorders, Secondary |
Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases |

